503A vs 503B Pharmacies for Compounded GLP-1 Medications
Understanding 503A vs 503B pharmacy compounding is the single most useful thing a patient can learn before choosing a compounded tirzepatide or semaglutide provider.
Last updated June 12, 2026. Reviewed by the GLP Agonists editorial team.
The core difference
| 503A pharmacy | 503B outsourcing facility | |
|---|---|---|
| Compounds for | A specific patient with a prescription | Larger batches, can supply clinics |
| Primary oversight | State boards of pharmacy | Registers with and inspected by the FDA |
| Manufacturing standard | USP <797>/<795> | cGMP (current Good Manufacturing Practice) |
| Patient-specific Rx required | Yes | Not always for stock, but dispensing to a patient requires a prescription |
Why it matters for safety
Neither pathway produces an FDA-approved drug, but 503B facilities operate under stricter cGMP manufacturing standards and FDA registration, while 503A pharmacies are overseen by state boards and tailor each prescription. Reputable telehealth providers disclose which type of pharmacy they use. A provider that will not tell you where your medication is compounded is a red flag.
What to ask your provider
- Is my medication compounded by a 503A pharmacy or a 503B facility?
- Is the pharmacy licensed in my state, and can you name it?
- What testing (potency, sterility) is performed?
- Who is the prescribing clinician and are they licensed in my state?
Safety & eligibility
GLP-1 medications are prescription-only and are not appropriate for everyone. They are generally not recommended if you have a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2, or a known hypersensitivity to the active ingredient. Caution applies with a history of pancreatitis, gallbladder disease, severe gastrointestinal disease, or diabetic retinopathy, and they are not used during pregnancy or breastfeeding. Common side effects include nausea, diarrhea, constipation, and reduced appetite. A licensed clinician reviews your history to decide whether treatment is appropriate — eligibility is a medical decision, not a checkout step.
Prescription requirement
Every legitimate provider listed here requires a valid prescription issued by a US-licensed clinician after an intake review. No reputable telehealth program sells GLP-1 medication without a prescription. If a website offers “tirzepatide” or “semaglutide” with no clinician review, treat it as a red flag and avoid it.